Abstract:Background: Resveratrol, a natural polyphenolic phytoalexin, has potent anti-tumor activity. Recently, it was found to induce autophagy in cancer cells. However, the effects of resveratrol on autophagy in non-small-cell lung cancer (NSCLC) cells have not yet been clearly elucidated. Materials and methods: A549 and H1299 cells were treated with different concentrations of resveratrol. Cell growth and apoptosis were measured by CCK-8 assay and flow cytometry, respectively. A549 cells were then treated with 200 μM resveratrol or SRT1720. Cell autophagy was detected by western blot and immunofluorescence. Results: In this study, we found that resveratrol exerted the anti-tumor effect through inhibiting cell proliferation and promoting cell apoptosis in NSCLC cells dose-dependently. Resveratrol has also increased the relative expression of Beclin1 and LC3 II/I while decreased p62 expression, suggesting that resveratrol induced autophagy in NSCLC cells. In addition, resveratrol increased SIRT1 expression and SIRT1 activator SRT1720-induced autophagy of NSCLC cells. SIRT1 knockdown reduced resveratrol-induced autophagy significantly. These results indicated that resveratrol might induce autophagy through upregulating SIRT1 expression. Moreover, inhibiting autophagy by autophagy inhibitor 3-methyladenine or SIRT1 inhibitor nicotinamide significantly suppressed proliferation while promoted apoptosis compared with the resveratrol 200 μM group, suggesting that resveratrol-induced autophagy might act as a protective mechanism to promote NSCLC cell survival and inhibiting autophagy can enhance the anti-tumor effect of resveratrol. Besides that, resveratrol treatment inhibited Akt/mTOR while p38-MAPK was activated in NSCLC cells in a dose-dependent manner. Activating Akt/ mTOR pathway by IGF-1 or inhibiting p-38-MAPK pathway by doramapimod significantly inhibited cell proliferation while increased cell apoptosis of NSCLC cells compared with the resveratrol 200 μM group. Conclusion: Taken together, our findings suggest that resveratrol inhibited proliferation but induced apoptosis and autophagy via inhibiting Akt/mTOR and activating p38-MAPK pathway. Resveratrol-induced autophagy might act as a protective mechanism to promote NSCLC cell survival. Therefore, inhibition of autophagy may enhance the anti-tumor activity of resveratrol in NSCLC.

Resveratrol induces autophagy-dependent apoptosis in HL-60 cells

Resveratrol Induces Autophagic Apoptosis Via the Lysosomal Cathepsin D Pathway in Human Drug-Resistant K562/ADM Leukemia Cells.

The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cells

GADD45α and Annexin A1 Are Involved in the Apoptosis of HL-60 Induced by Resveratrol.

Resveratrol Induces Gastric Cancer Cell Apoptosis Via Reactive Oxygen Species, but Independent of Sirtuin1.

Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK

Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy

Resveratrol Induces Apoptosis in K562 Cells through a Fas-Dependent Pathway

Resveratrol-induced Apoptosis is Enhanced by Inhibition of Autophagy in Esophageal Squamous Cell Carcinoma

Resveratrol Induces Autophagy and Apoptosis in Non-Small-Cell Lung Cancer Cells by Activating the NGFR-AMPK-mTOR Pathway

Resveratrol-mediated apoptosis in renal cell carcinoma via the p53/AMP‑activated protein kinase/mammalian target of rapamycin autophagy signaling pathway

Resveratrol Induced Apoptosis in Human Gastric Carcinoma SGC‐7901 Cells Via Activation of Mitochondrial Pathway

Resveratrol Induces Apoptosis in SGC-7901 Gastric Cancer Cells

Resveratrol Induced Apoptosis and Cell Arrest in Cancer Cells

Resveratrol Induces Apoptosis in Human Esophageal Carcinoma Cells

Beta-arrestin 2 Modulates Resveratrol-Induced Apoptosis and Regulation of Akt/GSK3β Pathways

Resveratrol Induces AMPK and Mtor Signaling Inhibition-Mediated Autophagy and Apoptosis in Multiple Myeloma Cells.

Reducing‐Autophagy Derived Mitochondrial Dysfunction during Resveratrol Promotes Fibroblast‐Like Synovial Cell Apoptosis

Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells.

Effects of Resveratrol on Cell Cycle and Apoptosis of Hepatocellular Carcinoma Cells and Its Possible Mechanism

Mechanism of Resveratoral Inducing Apoptosis in Human Small Cell Lung Cancer H446 Cells